• Home 
  • > About Us > 
  • History

History of CbsBioscience 씨비에스바이오사이언스는 2003년 창업이래 지속적인 연구개발을 통해 2010년 세계최초로 간암예후예측유전자 검사기술을 개발하여 상용화에 성공하였습니다.

  • Full‐scale domestic marketing of prognosis diagnostics for liver cancer
  • Expansion of overseas markets
  • Performing of the clinical trials for CbsFlatin and Nexavar based on liver cancer companion diagnostics
  • Organizing Company for "Post-genomic multi departments genome project" (Ministry of Health and Welfare)
  • Approval of IND for anticancer drug for liver cancer treatment from KFDA KFDA selected OncoHepaTest® as "PHARM NAVI" project for commercialization
  • OncoHepaTest® Q-Kit: Approved by KFDA (Class III in vitro diagnostics)
  • OncoHepaTest® CDx-Kit: Approved by KFDA (Class III in vitro diagnostics)
  • Contract for CRO research with Gachon univ. Medical Center ($ 1.52 M/3 years)
  • Development of anticancer drug for liver cancer treatment
  • Contract for OncoHepa Test with major Hospitals (AMC, HMC, SMC, AsMC, DMC, Korea Univ MCs (Anam, Guro, Ansan))
  • Invested by Korea Investment & Securities Co.
  • Korea Patent Registration ‘Prognostic marker for HCC’
  • Contract MOU with Asan Medical Center for the Development of Biomarker for Cancer
  • Licensed as New Health Technology by Ministry of Health & Welfare(2010.10)
  • Organizing Company for Regional Development of Industrial
  • Technology (Ministry of Knowledge Economy)
  • Started to provide OncoHepa Test (2010.11)
  • Project Initiation with Ajoo and Hanyang Univ. Medical Centers
  • Certification for Gene Research and Test Organization
  • Patent Application ‘Prognostic Marker for HCC’
  • Organizing Company for both Growth Engine Business and Strategic
  • Technologies Development (Ministry of Knowledge Economy)
  • Joined ‘Outstanding Research Center Business’ (MOSS)
  • Discovering Study Gene Marker for the Prognosis of HCC (Samsung Medical center, Postech)
  • Development of Diagnosis Expert System (SMC, KAIST)
  • Managing Company for Development Project of Leading Technology
  • Innovation (the Small & Medium Business Administration)
  • Name Change to CbsBioscience Inc.
  • INNOBIZ/Special Exception of Military Service
  • Developed the 2nd Operation System for FT-ICR in the KRISS
  • Venture Company confirmed
  • Joined ‘Regional R&D Cluster Project by the Commerce Ministry
  • Developed the 1st Operation System for FT-ICR MS in the KRISS
  • Research Center was established
  • Involved ‘Special R&D Project for Fisheries’ for the Ministry of Maritime
  • Affairs and Fisheries
  • CbsSoft Inc. is found
  • Organizing Company for the Government’s mid-term Basic Project